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Abstract
Consumption of cooked/processed meat and ethanol are lifestyle risk factors in the aetiology of breast cancer. Cooking meat 
generates heterocyclic amines such as 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Epidemiology, mechanistic 
and animal studies indicate that PhIP is a mammary carcinogen that could be causally linked to breast cancer incidence; 
PhIP is DNA damaging, mutagenic and oestrogenic. PhIP toxicity involves cytochrome P450 (CYP1 family)-mediated 
metabolic activation to DNA-damaging species, and transcriptional responses through Aryl hydrocarbon receptor (AhR) and 
estrogen-receptor-α (ER-α). Ethanol consumption is a modifiable lifestyle factor strongly associated with breast cancer risk. 
Ethanol toxicity involves alcohol dehydrogenase metabolism to reactive acetaldehyde, and is also a substrate for CYP2E1, 
which when uncoupled generates reactive oxygen species (ROS) and DNA damage. Here, using human mammary cells that 
differ in estrogen-receptor status, we explore genotoxicity of PhIP and ethanol and mechanisms behind this toxicity. Treat-
ment with PhIP  (10−7–10−4 M) significantly induced genotoxicity (micronuclei formation) preferentially in ER-α positive 
human mammary cell lines (MCF-7, ER-α+) compared to MDA-MB-231 (ER-α−) cells. PhIP-induced CYP1A2 in both 
cell lines but CYP1B1 was selectively induced in ER-α(+) cells. ER-α inhibition in MCF-7 cells attenuated PhIP-mediated 
micronuclei formation and CYP1B1 induction. PhIP-induced CYP2E1 and ROS via ER-α-STAT-3 pathway, but only in 
ER-α (+) MCF-7 cells. Importantly, simultaneous treatments of physiological concentrations ethanol  (10−3–10−1 M) with 
PhIP  (10−7–10−4 M) increased oxidative stress and genotoxicity in MCF-7 cells, compared to the individual chemicals. 
Collectively, these data offer a mechanistic basis for the increased risk of breast cancer associated with dietary cooked meat 
and ethanol lifestyle choices.
Keywords 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine · Ethanol · Estrogen receptor · Mammary carcinogen · 
Genotoxicity · CYP
Introduction
Epidemiology studies show that lifestyle choices such as 
consumption of red or processed meat and ethanol are con-
sistently associated with the development of cancers of the 
gastrointestinal tract, the mammary gland and the prostate 
(Abid et al. 2014; Boada et al. 2016; Cross et al. 2007; 
Major et al. 2011; Sinha et al. 2009; Willett 1994). This 
and supporting experimental data has prompted IARC to 
declare red meat as a Class 2A human carcinogen (probably 
carcinogenic in humans) and processed meat as a Class 1 
carcinogen (carcinogenic in humans) (https://www.iarc.fr/
en/media-centre/pr/2015/pdfs/pr240_E.pdf). The cooking of 
red and processed meat generates chemicals that are DNA 
damaging, mainly polycyclic aromatic hydrocarbons and 
heterocyclic amines (David et al. 2016; Felton et al. 1991; 
Holland et al. 2004; Sinha et al. 2005). 2-Amino-1-methyl-
6-phenylimidazo[4,5-b]pyridine (PhIP) is one of the most 
abundant heterocyclic amines present in well-done meat 
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(Gooderham et al. 1997) (Zheng and Lee 2009). PhIP is 
a genotoxic carcinogen that is metabolically activated by 
CYP1 family enzymes (particularly CYP1A2) to N-hydroxy-
PhIP (Boobis et al. 1994; Zhao et al. 1994). Subsequent 
esterification of the N-hydroxy metabolite produces unstable 
products that spontaneously form nitrenium ions and attack 
DNA to induce mutation (Gooderham et al. 2007; Langouet 
et al. 2002; Lynch et al. 1998; Turesky et al. 1998, 2002; 
Yadollahi-Farsani et al. 1996; Zhu et al. 2000). PhIP has 
been shown to induce tumours in rats in hormonally respon-
sive tissues (breast, prostate, colon) (Ito et al. 1991; Shirai 
et al. 1997) and is reported by IARC (https://monographs.
iarc.fr/ENG/Monographs/vol56/mono56-13.pdf, 1993) to be 
a Class 2B carcinogen (possibly carcinogenic to humans). 
In addition to being a genotoxic carcinogen, an important 
characteristic of PhIP is its hormone-like activity (estrogen-
like) (Lauber et al. 2004; Papaioannou et al. 2014). Estro-
gens, known to promote breast carcinogenesis (Liehr 2001), 
primarily act via two receptors, estrogen-receptor α (ER-
α) and ER-β with ER-α being more abundantly expressed 
(Hewitt and Korach 2003) in approximately two-thirds of 
breast tumors and its presence determines the responsiveness 
towards hormone therapy (Williams et al. 2008). Interest-
ingly, PhIP exhibits its estrogenic activity exclusively via 
ER-α (Lauber et al. 2004). The estrogenic behavior of PhIP 
has been shown to increase the invasiveness of breast cancer 
cells (Lauber and Gooderham 2011) but the role of ER in 
the genotoxicity and metabolic activation of PhIP has not 
been explored.
A number of cytochrome P450 enzymes (CYPs) are 
known to be involved in metabolism of steroid hormones, 
particularly CYP1A1, 1A2 and 1B1 (Go et al. 2015). Addi-
tionally, CYP2E1 is reported to be differentially expressed in 
hormone-responsive MCF-7 cells compared to non-respon-
sive MDA-MB-231 cells (Leung et al. 2013). Moreover, 
female steroid hormones (estrogen and progesterone) are 
known to regulate CYP2E1 expression (Konstandi et al. 
2013). In view of the regulation of CYP2E1 via estrogen 
and the hormone-like activity (estrogen) of PhIP (Lauber 
and Gooderham 2007), the possibility exists that PhIP might 
regulate CYP2E1 expression.
Epidemiology shows that consumption of ethanol is asso-
ciated with breast cancer (Hamajima et al. 2002; Singletary 
and Gapstur 2001; Smith-Warner et al. 1998), with an intake 
of 10 g ethanol per day (approximately 1.25 units) increasing 
the risk of breast cancer between 6–10% (IARC 2012 https://
monographs.iarc.fr/ENG/Monographs/vol96/mono96.pdf). 
Social consumption of ethanol readily achieves mM plasma 
concentrations. The risk is dose-dependent and the evidence 
that alcoholic drinks are a cause of pre- and post-meno-
pausal breast cancer is sufficiently convincing that IARC 
have classed ethanol as a class 1 carcinogen (carcinogenic 
in humans) (https://monographs.iarc.fr/ENG/Monographs/
vol96/mono96.pdf). Although ethanol can be metabolised 
to acetaldehyde, which forms adducts with DNA (Abraham 
et al. 2011), overall the case for ethanol being a genotoxic 
carcinogen is weak (https://www.gov.uk/government/pub-
lications/consumption-of-alcoholic-beverages-and-risk-of-
cancer), and a non-genotoxic mode of action is likely to 
contribute. Thus, although epidemiological evidence sup-
ports a positive association between alcohol intake and the 
risk for breast cancer, a mechanistic understanding of this 
association is lacking.
In the present work, we describe mechanistic studies that 
explore the toxicity of PhIP and ethanol and their respective 
abilities to damage DNA. We further show the involvement 
of ER-α and that ethanol can potentiate the genotoxicity of 
the mammary carcinogen PhIP through mutually interactive 
biochemistry.
Methods
Cell culture and treatment
The human breast adenocarcinoma MCF-7 (ER-α+) and 
MDA-MB-231 (ER-α−) cell lines were purchased from 
ATCC (LGC Prochem, Middlesex,UK) and were grown 
in minimum essential medium (MEM) (GIBO, Life tech-
nologies, Paisley, UK) supplemented with 10% fetal bovine 
serum (FBS), 100 units/ml of penicillin and streptomycin 
100 µg and 2 mM L-glutamine. Cells were cultured routinely 
in 75-cm2 flasks in a humidified incubator at 37 °C, 5%  CO2. 
Prior to treatment, cells (MCF-7 and MDA-MB-231) at a 
density of 25,000 cells/well in 24-well plates, were cultured 
in MEM supplemented with 5% dextran-coated charcoal-
stripped FBS (Stripped media) for 72 h. Cells were treated 
with PhIP (0–100 µM, Toronto Research Chemicals Inc., 
Toronto, Canada) and Estradiol  (E2) dissolved in dimethyl 
sulphoxide (DMSO). For treatment with estrogen-receptor 
inhibitor, cells were co-treated with PhIP and selective estro-
gen inhibitor Fulvestrant ICI 182,780 (ICI) (Sigma-Aldrich) 
for 24 h. PhIP,  E2 and ICI were dissolved in DMSO.
For STAT3 inhibition, cells were co-treated for 24 h with 
PhIP and 25 µM STAT3 inhibitor (STAT3 inhibitor VIII 
5, 15 diphenylporphyrin, Millipore, Feltham, UK). STAT3 
inhibitor was dissolved in DMSO. For ethanol treatment, 
media was supplemented with different concentrations of 
ethanol (10 mM-100 mM, Sigma-Aldrich) and was added 
to the cells. In some experiments, N-acetyl-cysteine (NAC) 
(10 mM, Sigma-Aldrich) diluted in phosphate-buffered 
saline (PBS) was added to incubations.
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Cytotoxicity and micronucleus assay
Cytotoxicity and micronucleus (MN) assays were per-
formed according to OECD guidelines adapted to MCF-7 
and MDA-MB-231 cells. Briefly, cells were seeded at a 
density of 5 × 104 cells per well in 24-well plate. Cells were 
treated with PhIP or ethanol as detailed previously. Follow-
ing treatment with chemicals and harvesting (48 h), cells 
were trypsinised, the cell concentration adjusted to 2 × 105 
and re-suspended in serum-free  R0 (serum-free media) with 
2% pluronic acid medium (GIBCO, Life technologies) and 
cytotoxicity was determined by counting cells in a haemocy-
tometer with TrypanBlue exclusion (GIBCO, Life technolo-
gies). For the MN assay, cells were spread on a microscope 
slide using a cytospin. Cells at a density of 2 × 104 cells 
per slide were fixed with 100% methanol and stained for 
60 s with acridine orange (0.1 mg  ml−1 dissolved in PBS, 
Sigma-Aldrich). Frequency of MN was scored in 2000 cells 
per sample and three biological replicates were performed 
per treatment. Etoposide (1.25 µM) was used as a positive 
control.
Reverse transcription quantitative polymerase 
chain reaction (RT‑qPCR)
Following treatment, cells were lysed using TRIZOL rea-
gent and chloroform (0.2 ml) was added in each sample and 
centrifuged 12,000xg (10 min 2–8 °C). The upper aqueous 
phase was transferred to a fresh tube and 5 µg of RNase-
free glycogen (as carrier to aqueous phase) and 0.5 ml of 
isopropyl alcohol was added to precipitate RNA and incu-
bated (37 °C, 10 min). Following incubation, lysates were 
centrifuged at 12,000xg (10 min 2–8 °C). The gel-like pellet 
was washed with ethanol and re-dissolved in RNase-free 
water with heating (55–60 °C). Extracted RNA was quanti-
fied by UV spectroscopy (UV–VIS Nano-spectrophotom-
eter, Implen, Essex, UK) and purity was assessed from 
260/280 nm and 260/230 nm ratios. Reverse transcription 
(RT) of extracted RNA (100–500 ng) was completed accord-
ing to manufacturer’s protocol (Invitrogen) and qPCR was 
performed using predesigned Taqman gene expression 
assays and FAST PCR master mix (Taqman, Applied Bio-
systems, Life technologies) using a StepOnePlus fast real-
time PCR system (Applied Biosystems, Life technologies). 
Target gene expression was normalized to GAPDH and 
quantified using the delta-Ct method (Livak and Schmitt-
gen 2001).
ROS assay
Production of reactive oxygen species (ROS) was measured 
using 2′,7′–dichlorofluorescein diacetate method. Carboxy-
2′,7′-dichlorofluorescein diacetate (carboxy-DCF-DA) is 
taken up by viable cells and cleaved by endogenous esterases 
to the nonfluorescent derivative, reduced carboxy-dichloro-
fluorescein (carboxy-DCFH). This product is retained in the 
cytosol where it can be oxidized by intracellular ROS to the 
highly fluorescent product, oxidised carboxy-dichlorofluo-
rescein (carboxy-DCF). The intensity of fluorescence is pro-
portional to intracellular ROS levels. MCF-7 cells (2 × 104/
well) were seeded into 24-well plates in 1% FBS and allowed 
to attach overnight. Cells were treated with PhIP for 24 h 
and then treated with Carboxy-DCFDA (20 µL, 30 µM) in 
media containing 1% FBS (1 ml) and incubated for 30 min 
at 37 °C, washed with PBS and new media (1% FBS) was 
added. Fluorescent measurements (excitation at 485 nm and 
emission at 520 nm) were then taken from 10 min to 24 h 
using a fluorescence plate reader (BMG POLARstar Galaxy 
Labtech, Ortenberg, Germany). The concentration of DMSO 
(0.2%) was identical in all treatments and had no effect on 
ROS production at this concentration.
Statistical analysis
The difference in treatments vs. control was compared by 
one-way analysis of variance (ANOVA) followed by a Dun-
nett’s post test. Data were obtained from measurements 
made in at least three independent cultures and presented as 
a mean ± standard error (SEM). Pearson’s correlation coeffi-
cient test was used for correlation analysis (GraphPad Prism 
5, GraphPad Software Inc., La Jolla, CA, USA).
Results
Does estrogen‑receptor modulate PhIP 
genotoxicity?
The genotoxicity of PhIP is well established (Boyce et al. 
2014; Brooks et al. 1994; Lynch et al. 1998; Yadollahi-
Farsani et al. 1996). In the present study, we have assessed 
genotoxicity using an adapted micronucleus assay and show 
that PhIP is a potent inducer of micronuclei in ER receptor-
positive MCF-7 cells but not MDA-MB-231 cells (Table 1). 
Compared to control, the highest concentration of PhIP 
(100 µM) showed approximately a tenfold induction in MN 
formation in MCF-7 cells and threefold in MDA-MB-231 
cells (Table 1). Since ER-α is expressed in MCF-7 cells (but 
not MDA-MB-231 cells), while ER-β is weakly expressed 
in both cell lines (Vladusic et al. 2000), this suggests a pos-
sible role for ER-α in the increased genotoxicity of PhIP in 
MCF-7 cells compared to MDA-MB-231 cells. To examine 
the role of ER receptor, we investigated the genotoxicity of 
PhIP after blocking the ER-α-receptor using the potent and 
selective ER receptor antagonist ICI 182,780 (Bender and 
Veney 2008).
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No significant change in the cell survival was observed 
following treatments with PhIP, etoposide (positive control) 
or estradiol (Fig. 1a, b). Co-treatment with ICI significantly 
attenuated (p < 0.001) MN formation following treatment 
with PhIP in MCF-7 (Fig. 1c), while in MDA-MB-231, no 
change in the DNA damaging ability of PhIP in the presence 
of ER antagonist was observed (Fig. 1d). These data support 
a role of ER-α in the increased genotoxicity of PhIP and sug-
gest that ER-β does not play a role. MN induction by etopo-
side, the positive control, was not affected by co-incubation 
with ICI (Fig. 1). In contrast,  E2-mediated genotoxicity was 
attenuated with ICI in MCF-7 but not MDA-MB-231 cells 
(Fig. 1). Overall, the genotoxicity data suggest that ER-α can 
regulate the genotoxicity of both PhIP and E2.
Role of ER receptor in the metabolic activation 
of PhIP
The genotoxicity of PhIP is dependent upon CYP1 family-
mediated metabolic activation to N-hydroxy PhIP (Boo-
bis et al. 1994; Zhao et al. 1994). This metabolite can be 
esterified by sulphotransferase to generate metabolites that 
readily form nitrenium derivatives capable of attacking 
DNA (Buonarati and Felton 1990; Chevereau et al. 2017; 
Langouet et al. 2002; Turesky et al. 1998, 2002). Thus, 
we investigated whether PhIP can induce gene expression 
of these enzymes. The results show that PhIP can induce 
CYP1A2/1B1 in both cell lines but that CYP1B1 induc-
tion in ER-α (+) MCF-7 was higher compared to ER-α (−) 
MDA-MB-231 cells (Fig. 2). PhIP failed to induce CYP1A1 
in either cell line (data not shown). To further examine the 
role of ER-α in the regulation of CYP1B1 induction, both 
cell lines were co-treated with PhIP and ER inhibitor ICI 
for 24 h and CYP1B1 mRNA expression was determined 
by qPCR.  E2 (1 µM) was used as a positive control, being 
the endogenous ligand for the ER receptor. Interestingly, 
 E2 upregulated CY1B1 expression in ER-α (+) MCF-7 cell 
line only and this increase was attenuated significantly by 
co-treatment with ER inhibitor ICI, suggesting the possible 
role of ER-α in the regulation of CYP1B1 mRNA (Fig. 2b). 
No significant change compared to vehicle control in 
CYP1A2 mRNA expression was observed by  E2 treatments 
in either cell line, implying the role of  E2 in the regulation 
of CYP1B1 only. Overall, this suggests that  E2 regulates 
CYP1B1 expression via ER-α receptor. PhIP-mediated 
induction of CYP1B1 was significantly inhibited (p = 0.05) 
by concurrent treatment with ICI (Fig. 2B) in MCF-7 cells 
only, indicating that PhIP can induce CYP1B1 via ER-α in 
ER-α (+) MCF-7 cells. Upregulation of CYP1A2 mRNA 
expression by PhIP was unaffected by ICI treatment in both 
cell lines (Fig. 2a, c). Overall, PhIP can upregulate CYP1A2 
in both cell lines, probably via AhR, while its effects on 
CYP1B1 are ER-α mediated. Collectively, these multiple 
CYP induction mechanisms employed by PhIP can potenti-
ate PhIP genotoxicity in ER-α (+) mammary cells.
CYP2E1 induction by PhIP
Previous reports indicating that estrogen can regulate 
CYP2E1 (Konstandi et  al. 2013) and the hormone-like 
activity (estrogenic) of PhIP (Lauber et al. 2004; Lauber and 
Gooderham 2007, 2011) suggest that PhIP might regulate 
CYP2E1, thus we investigated this in the current study. The 
results show that PhIP treatment induced CYP2E1 mRNA 
expression in a dose-dependent manner in hormone-respon-
sive MCF-7 cells (but not in MDA-MB-231 cells) (Fig. 3a).
Recently, our laboratory has shown that transcription of 
STAT3 (Signal transducer and activator of transcription 3) 
is involved in the upregulation of CYP2E1 expression (Patel 
et al. 2014). Others have reported that miR378 can regulate 
CYP2E1 via translational repression (Mohri et al. 2010). 
To examine the roles of these mediators, we looked at the 
expression of miR378 and STAT3 mRNA in PhIP-treated 
MCF-7 cells (PhIP increased CYP2E1 expression). Follow-
ing 24 h PhIP treatment, no change in miR378 expression 
was observed (Fig. 3b), whereas a dose-dependent upregula-
tion of STAT3 mRNA expression was seen (Fig. 3b). This 
Table 1  The cytotoxicity and 
genotoxicity (micronucleus 
formation) of PhIP-treated 
MCF-7 and MDA-MB-231 
mammary cells
a Percent survival ± Standard Deviation (SD), mean of three independent cultures, two slides per culture
b Micronucleus (MN) frequency presented as MN/1000 cells, mean of three independent cultures ± SD, two 
slides per culture, 1000 cells/slide counted
MCF-7 cells MDA-MB-231 cells
Cytotoxicitya MN  frequencyb Cytotoxicitya MN  frequencyb
Control 89% ± 1 3.5 ± 0.5 88.9% ± 7.2 3.5 ± 1
PhIP 100 nM 86% ± 2.4 12.8 ± 5.1 87.2% ± 0.9 3.2 ± 2.5
PhIP 1 µM 85.6% ± 2.4 22.3 ± 2.6 88.1% ± 0.9 4.7 ± 1.8
PhIP 10 µM 85.8% ± 2.6 29.2 ± 3.4 90.4% ± 4.3 9 ± 0.9
PhIP 100 µM 82.7% ± 1.7 49 ± 3.5 87.7% ± 1.5 13.7 ± 1.3
Etoposide 81.7% ±1.4 172 ± 4.8 83.7% ± 2.3 121 ± 27.7
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implies that miR378 has no role in PhIP-mediated CYP2E1 
upregulation in MCF-7 cells. In contrast, a statistically sig-
nificant (p ≤ 0.0001) correlation was found between STAT3 
and CYP2E1 mRNA expression (Fig. 3c). As STAT3 is acti-
vated by Janus kinase 2 (JAK2), JAK2 mRNA expression 
was determined in PhIP-treated MCF-7 cells and a dose-
dependent increase was seen (Fig. 3b). This suggests that 
PhIP can activate JAK/STAT3 pathway in the ER-α positive 
MCF-7 cells.
To further test the role of STAT3, MCF-7 cells were co-
treated with the STAT3 inhibitor VIII 5, 15-diphenylporphy-
rin (25 µM) and PhIP for 24 h and CYP2E1 expression was 
determined by qPCR. Incubation with the STAT3 inhibitor 
completely abolished CYP2E1 mRNA upregulation by PhIP 
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Fig. 1  Effect of estrogen-receptor antagonist ICI, 182, 780 on the 
genotoxicity of PhIP in breast cells: Cells were harvested 48 h post 
treatment (24 h). Cytotoxicity is expressed as % cell survival as meas-
ured by cell counting using haemocytometer (a, b). Genotoxicity of 
PhIP measured by micronucleus (MN) frequency in presence/absence 
of ICI 182,780 in MCF-7 (c) and MDA-MB-231 (d) cells. Etoposide 
was used as a positive control. MN frequency per 1000 cells was 
measured following treatment (1000/slide and two slides per culture). 
Statistically significant differences between PhIP vs. PhIP & ICI 182, 
780 co-treated samples were assessed by Student’s t test in GraphPad 
Prism 6. Significance is shown in p values; ***p < 0.001, **p < 0.01, 
*p < 0.05, NS no significant difference. Error bars represent the stand-
ard error of the mean (SEM) for independent cultures (n = 3)
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further supporting the involvement of STAT3 in its regula-
tion (Fig. 4a).
Interestingly, PhIP increased CYP2E1 mRNA expres-
sion only in ER-α (+) MCF-7 cells (Fig. 3). PhIP has 
potent estrogenic activity mediated via ER-α (Lauber 
et al. 2004) and recently it has been shown that ER-α 
binds to STAT3 and JAK2 resulting in upregulation of 
JAK2-mediated STAT3 expression (Binai et al. 2010). 
We hypothesized that PhIP can activate ER-α to trigger 
the JAK/STAT pathway leading to the overexpression 
of CYP2E1. To investigate this, STAT3 and CYP2E1 
mRNA expression was determined in MCF-7 cells fol-
lowing co-treatment with PhIP and ICI. ICI inhibited the 
PhIP-mediated STAT3 increase (Fig. 4b), and treatment 
with the ER inhibitor ICI significantly blocked CYP2E1 
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Fig. 2  Induction of CYP1A2 and CYP1B1 mRNA expression by 
PhIP; in MCF-7 (a, b) and MDA-MB-231 (c, d) cells measured by 
RT-qPCR. Data were normalized to expression of GAPDH and are 
shown relative to control (0.2% DMSO). Statistically significant 
differences between PhIP vs. PhIP & ICI 182, 780 co-treated sam-
ples were assessed by Student’s t test and between control (0.2% 
DMSO) and treated samples using one-way ANOVA with a Dun-
nett’s post test in GraphPad Prism 6. Significance is shown in p val-
ues; ***p < 0.001, **p < 0.01, *p < 0.05, NS no significant difference. 
Error bars represent the standard error of the mean (SEM) for inde-
pendent cultures (n = 3)
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expression (Fig. 4c). The proposed mechanism for these 
interactions is summarised in Fig. 4d.
Can CYP2E1 induction lead to ROS production 
by PhIP?
After establishing the induction of CYP2E1 mRNA by PhIP, 
we investigated whether CYP2E1 induction resulted in the 
generation of reactive oxygen species (ROS), since CYP2E1 
enzyme is easily uncoupled leading to potent induction of 
ROS (Jimenez-Lopez and Cederbaum 2005), and ROS 
production may play an important role in tumor initiation 
and progression (Cerutti 1985; Slaga et al. 1981; Trush and 
Kensler 1991).
A dose-dependent increase in ROS levels was recorded 
following the treatment of MCF-7 cells (but not MDA-
MB-231 cells) with PhIP (Fig. 5a). The effect was pro-
nounced over the first 60 min then returned to control lev-
els. This supports the hypothesis that CYP2E1 enzyme is 
involved in the generation of ROS in MCF-7 cells.
Since the STAT3 inhibitor completely blocked CYP2E1 
mRNA expression, it was important to establish if STAT3 
inhibition could modulate ROS generation. MCF-7 cells 
were treated with 100 µM PhIP (for 24 h) in the presence 
and absence of STAT3 inhibitor (25 µM) and ROS produc-
tion was monitored. STAT-3 inhibitor significantly reduced 
ROS production by PhIP, providing evidence that CYP2E1 
is a regulator of ROS production (Fig. 5b). Significantly, 
the addition of STAT3 inhibitor failed to attenuate the 
 H2O2-induced ROS (Fig. 5b). However, it is important to 
note, although STAT3 inhibitor significantly inhibited ROS 
production, PhIP was still able to promote an oxidative stress 
response, implying that residual levels of CYP2E1 enzyme 
remained prone to uncoupling.
Can co‑exposure to ethanol and PhIP, potentiate 
DNA damage in mammary cells?
Our data show that PhIP can regulate CYP2E1-mediated 
oxidative stress, and the question arises whether these cellu-
lar affects could play a role in the initiation or progression of 
PhIP-induced mammary cancer. Interestingly, ethanol also 
upregulates oxidative stress via CYP2E1 enzyme (Jin et al. 
2013), which suggests that co-exposure to PhIP and ethanol 
could potentiate DNA damage. As red meat and cigarette 
smoke (both a source of PhIP) and ethanol consumption are 
the most important modifiable lifestyle risk factors for breast 
cancer (Scoccianti et al. 2014b; Stein and Colditz 2004), we 
investigated if together these two lifestyle carcinogens can 
potentiate DNA damage in mammary cells.
CYP2E1 upregulation by co‑treatment of ethanol 
and PhIP
CYP2E1 expression and activity are reported to play an 
important role in mammary carcinogenesis and provide a 
link between ethanol metabolism and progression of breast 
cancer (Leung et al. 2013). Published data show ethanol 
is capable of increasing CYP2E1, (Jin et al. 2013), (Rob-
erts et al. 1995) and is known to increase ROS production 
(Bailey et al. 1999), (Sanchez-Alvarez et al. 2013), (Leon-
Buitimea et al. 2012). Taking into consideration circulating 
ethanol levels after human alcohol consumption, CYP2E1 
activity, and ROS production, we examined the effect of 
ethanol on MCF-7 cells. Since concentrations ranging from 
10 to 100 mM correspond to the circulating levels of ethanol 
in blood following moderate to heavy drinking (Singletary 
et al. 2001), cells were treated with ethanol 10 to 100 mM 
and CYP2E1 mRNA expression was determined by qPCR. 
A dose-dependent increase in CYP2E1 expression was 
observed, which was significant at 50–100 mM (Fig. 6a).
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Fig. 3  CYP2E1 mRNA expression mediated by PhIP in breast cells. 
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measured by RT-qPCR. The involvement of miR378 and JAK/STAT3 
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cells is shown in (c). Statistical significance was calculated by linear 
regression in GraphPad Prism 6, ***p < 0.001. Error bars represent 
SEM for independent cultures (n = 3)
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We then examined the effect of co-treatment of 50 mM 
of ethanol and 100 µM of PhIP and a significant increase 
(p = 0.0144) in CYP2E1 mRNA expression was seen fol-
lowing co-treatment compared to ethanol or PhIP alone 
(Fig. 6b).
Combined effect of ethanol and PhIP on ROS 
production
Although epidemiological studies provide convincing evi-
dence about the involvement of ethanol in the increased 
incidence of breast cancer (Hamajima et al. 2002; Smith-
Warner et al. 1998), the underlying molecular or cellular 
mechanisms are still not clear. The metabolism of ethanol 
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Fig. 4  Role of estrogen receptor (ER) and STAT3 in CYP2E1 induc-
tion by PhIP in MCF-7 cells: CYP2E1 mRNA expression in the pres-
ence of STAT3 inhibitor 25  µM (a), STAT3 mRNA expression in 
the presence of PhIP and ICI 182,780 in MCF7 cells (b), CYP2E1 
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DMSO (0.2%) was used as vehicle control. Statistically significant 
differences between PhIP vs. PhIP & ICI 182, 780/STAT-3 inhibi-
tor co-treated samples were assessed by Student’s t test in GraphPad 
Prism 6. ***p < 0.001, **p < 0.01, *p < 0.05. Error bars represent the 
standard error of the mean (SEM) for independent cultures (n = 3). 
Proposed mechanism of PhIP-mediated CYP2E1 induction (d)
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by CYP2E1 and generation of ROS suggests a mechanism 
that can trigger genetic damage and/or maintain the tumor 
environment (Aye et al. 2004; Leung et al. 2013). Since 
our data show PhIP can induce oxidative stress (Fig. 5a), 
and recently it has been reported that ethanol can induce 
DNA damage via ROS generation (Guo et al. 2008; Kayani 
and Parry 2010) it was important to establish the effects 
of combinations of PhIP and ethanol on ROS formation.
MCF-7 cells were treated with ethanol (50 mM), PhIP 
(100 µM) or ethanol (50 mM) plus PhIP (100 µM) co-
treatment and ROS production determined. Elevated 
intracellular ROS levels were observed by all treatments, 
with a statistically significant increase in ROS seen with 
Fig. 5  ROS generation fol-
lowing PhIP treatments in 
mammary cells: ROS produc-
tion following PhIP treatments 
in MCF-7 and MDA-MB-231 
cells (a) over 10 and 60 min. 
The effect of STAT-3 inhibi-
tion on ROS generation by 
PhIP was assessed in MCF-7 
cells pretreated with PhIP with 
or without STAT-3 for 24 h 
and ROS (b) was monitored 
from 10 to 60 min. Statistically 
significant differences between 
PhIP vs. PhIP & STAT-3 co-
treated samples were assessed 
by Student’s t test in GraphPad 
Prism 6. **p < 0.01, NS not 
significant. Error bars represent 
the standard error of the mean 
(SEM) for independent cultures 
(n = 3)
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co-treatment of PhIP plus ethanol compared to ethanol 
alone, at time points up to 60 min (Fig. 6c).
Overall, the ROS production (Fig. 6c) and increased 
CYP2E1 expression data (Fig. 6b) following co-treatment 
(PhIP + Ethanol) are consistent, suggesting increased 
CYP2E1 expression could be responsible for elevated 
ROS production.
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Fig. 6  Increase in CYP2E1 expression and ROS generation by co-
treatment of PhIP and ethanol: MCF-7 cells treated with ethanol 
(a) or PhIP 100  µM and ethanol 50  mM (b) for 24  h and CYP2E1 
expression was determined by qPCR. Increase in ROS generation by 
co-treatment of PhIP and ethanol (c) in MCF-7 cells. Data is shown 
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in GraphPad Prism 6, ***p < 0.0001–0.001, **p < 0.001–0.01. Error 
bars represent standard error of the mean (SEM) for independent cul-
tures (n = 3)
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Fig. 7  Increase in the genotox-
icity of PhIP by ethanol: MCF-7 
cells were treated with ethanol, 
PhIP or ethanol plus PhIP for 
24 h, following treatment cells 
were allowed to recover for 48 h 
and then analyzed for cytotox-
icity (a) and genotoxicity (b). 
micronucleus (MN) frequency 
per 1000 cells was measured 
following treatment (1000 
cells/slide and two slides per 
culture). Etoposide was used as 
the positive control. Ethanol-
induced ROS was inhibited by 
the addition of N-acetyl cysteine 
(NAC) (c). Inclusion of NAC in 
incubations did not affect cyto-
toxicity (d), but ethanol plus 
PhIP-mediated genotoxicity was 
attenuated (e). Data are shown 
relative to control 0.1% DMSO. 
Statistically significant differ-
ences for treatments vs. control 
were calculated using one-way 
ANOVA with a Dunnett’s 
post test in GraphPad Prism 6, 
***p < 0.001, **p < 0.01. Error 
bars represent standard error of 
the mean (SEM) for independ-
ent cultures (n = 3). Statistically 
significant difference between 
the indicated treatments was 
determined by Student’s t test 
GraphPad Prism 6, **p < 0.01, 
*p < 0.05, NS not significant
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Can increase in ROS production lead 
to genotoxicity?
Increased oxidative stress can trigger or maintain the tumor 
environment and can also initiate tumorigenesis by inducing 
DNA damage (Cooke et al. 2003). Ethanol was generally 
considered non-genotoxic when examined in-vitro (Phil-
lips and Jenkinson 2001), but recently it has been reported 
that ethanol can induce DNA damage via ROS generation 
(Guo et al. 2008; Kayani and Parry 2010). It is also perti-
nent that heterocyclic amines can be oxidatively activated 
by ROS to DNA damaging species (Banning et al. 1993). 
Since our data show simultaneous treatment with ethanol 
and PhIP-increased oxidative stress (Fig. 6c), and since ROS 
generation can induce oxidative DNA damage (Cooke et al. 
2003), the genotoxicity of PhIP in the presence of ethanol 
was evaluated.
MCF-7 cells were treated with PhIP (100 µM), ethanol 
(50 mM) or PhIP plus ethanol for 24 h, cells were harvested 
after 48 h and analysed for cytotoxicity and genotoxicity 
(MN induction). A minimal decrease in cell survival was 
seen with treatments (Fig. 7a). Treatment with ethanol 
did not significantly induce MN, consistent with previous 
reports (Phillips and Jenkinson 2001) (Fig. 7b). However, a 
significant increase in the genotoxicity was seen following 
co-treatment of ethanol with PhIP compared to PhIP alone 
(Fig. 7b), consistent with the notion that high levels of ROS 
generation can contribute to the DNA damage. No change in 
the genotoxicity of etoposide by the addition of ethanol was 
observed (Fig. 7b). This is entirely consistent with the geno-
toxic action of etoposide (topoisomerase inhibition), which 
is independent of ROS involvement. These data indicate that 
ethanol potentiated the effect of the other ROS-generating 
agent (PhIP), leading to increased oxidative DNA damage. 
We suggest that the increased level of DNA damage is linked 
to the PhIP-induced expression of CYP2E1, which in turn 
potentiates activation of ethanol to DNA-damaging ROS. 
We further suggest that the generation of ROS could also 
activate PhIP by one electron oxidation to DNA damaging 
species. This mechanism proposes that ethanol can indirectly 
increase the genotoxicity of other chemicals (e.g., PhIP in 
meat) that are routinely consumed with alcohol.
To further confirm that the increase in the genotoxicity of 
PhIP in the presence of ethanol is due to ROS production, 
we attempted to block the production of ROS and investi-
gate the effect on genotoxicity. N-acetyl-cysteine (NAC) is 
a ROS scavenger and shown previously to abolish accumu-
lation of ROS at 10 mM concentration in MCF-7 cells (Li 
et al. 2013; Martinez-Outschoorn et al. 2010). Cells were 
treated with 50 mM of ethanol and 50 mM of ethanol plus 
10 mM of NAC and examined for ROS generation; a clear 
decrease in ROS production was seen in the presence of 
NAC (Fig. 7c). The effect of treatment of MCF-7 cells with 
ethanol (50 mM) and PhIP (100 µM) in the presence of NAC 
(10 mM) was investigated and the cytotoxicity and genotox-
icity (MN induction) examined. Treatment with NAC did not 
affect cell survival (Fig. 7d). Addition of NAC decreased 
the genotoxicity of PhIP plus ethanol significantly (p = 0.01) 
(Fig. 7e), providing evidence that by blocking ROS produc-
tion, the genotoxicity is decreased. Importantly, NAC had 
little effect on the genotoxicity of positive control etoposide 
(Fig. 7e), consistent with etoposide’s different mechanism 
of DNA damage (topoisomerase inhibition).
Discussion
The cooked food-derived mutagen PhIP is a genotoxic rat 
procarcinogen. PhIP is metabolically activated by the CYP1 
family of enzymes (particularly CYP1A2) to N-hydroxy-
PhIP (Boobis et al. 1994; Zhao et al. 1994). Subsequent 
esterification of the N-hydroxy metabolite produces unsta-
ble products that spontaneously form nitrenium ions that 
react with DNA to form covalent adducts that, unless 
repaired, may lead to mutagenesis (Buonarati et al. 1990; 
Chevereau et al. 2017; Crosbie et al. 2000; Langouet et al. 
2002; Turesky et al. 2002). Generally, metabolic activa-
tion of procarcinogens occurs in the liver where there is an 
abundance of CYP enzymes expressed (Guengerich 2017). 
Indeed the highest levels of CYP1A2 expression in the rat 
occurs in the liver, yet PhIP is not a hepatic carcinogen in 
the rat. PhIP can also act as a substrate for CYP1A1 and 
CYP1B1 enzymes, which can convert it to the genotoxic 
N-hydroxy metabolite (Boobis et al. 1994; Zhao et al. 1994). 
Both CYP1A1 and CYP1B1 are expressed extra-hepatic and 
are under regulatory control of the Ah receptor (Hankinson 
2016). Dietary exposure of rats to PhIP results in tumours of 
the colon, mammary gland and the prostate (Ito et al. 1991; 
Shirai et al. 1997), which aligns with diet-associated cancers 
in humans (Gooderham et al. 2007, 1996). PhIP has, there-
fore, been studied as a potential model dietary carcinogen. 
Whilst the CYP1 family-mediated activation and esterifica-
tion of PhIP is well understood as the genotoxic mode of 
action, the tissue specificity of PhIP’s carcinogenicity is not 
so well understood.
We have previously reported that PhIP has hormonal-like 
activity being able to act as an ER ligand with specificity 
for ER-α (Lauber et al. 2004; Lauber and Gooderham 2007, 
2011). This latter property of PhIP is known to promote 
human mammary cell proliferation (Lauber et al. 2004; Lau-
ber and Gooderham 2007), cell migration and invasion (Lau-
ber and Gooderham 2011). All of these events are key to 
the development of cancer. Whilst undoubtedly a genotoxic 
carcinogen, the additional hormone-like properties of PhIP 
are consistent with its tissue-selective tumourigenicity in 
rats (breast, prostate and colon) (Ito et al. 1991; Shirai et al. 
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1997). Importantly, PhIP’s specificity for ER-α appears to be 
a key activity in its ability to drive the cancer process. This 
ER-α specificity is further emphasized in the present study.
The role of ER‑α in the genotoxicity of PhIP in MCF‑7 
cells
The current study has shown that PhIP is a powerful inducer 
of genotoxicity in MCF-7 cells but less effective in MDA-
MB-231 cells. Previously, Fischer and colleagues demon-
strated that estradiol can induce micronuclei in MCF-7 but 
not in MDA-MB-231 cells (Fischer et al. 2001); similar 
responses have been reported for the estrogenic compound 
bisphenol A (Iso et al. 2006), suggesting the selective geno-
toxicity of estrogenic compounds in hormone responsive cell 
line (MCF-7). In line with this, here we show the genotox-
icity of PhIP is inhibited by treatment with ER antagonist 
ICI182780 in MCF-7, but is unaffected in MDA-MB-231 
cells.
In the present study, we link PhIP-mediated induction of 
CYP1B1 to selective genotoxicity in MCF-7 cells, compared 
to MDA-MB-231 cells. MDA-MB-231 cells only express 
ER-β and MCF-7 cells express both ER-α and ER-β. PhIP 
displays its estrogenic effects selectively via ER-α (Lauber 
et al. 2004), thus PhIP-mediated induction of CYP1B1 in 
MCF-7 cells is likely through the same mechanism of ER-α-
ERE (estrogen responsive element) interaction. Inhibition of 
PhIP-mediated CYP1B1 mRNA induction by ER antagonist 
(ICI 182,780), strongly supports the role of ER receptor in 
CYP1B1 gene regulation in MCF-7 cells. Consistent with 
this, Tsuchiya et al. (2004) and others showed that estradiol 
could induce CYP1B1 expression in ER-α-positive MCF-7 
cells but not in ER-α-negative MDA-MB-345 cells, by direct 
interaction of liganded-ER-α with ERE on the CYP1B1 
gene (Tsuchiya et al. 2004) (Han et al. 2010; Mookherjee 
et al. 2012). Estradiol has the ability to induce tumorigenic 
potential in benign MCF-10F cells and knock-down of ER-α 
receptor can delay the onset of tumors in rats (Santen et al. 
2009), suggesting that ER-α activation by xenoestrogens 
such as PhIP can have similar implications as estradiol.
CYP2E1‑mediated ROS generation by PhIP
CYP2E1 is primarily expressed in liver but has been 
detected in other tissues such as breast, brain, kidney and 
lungs (Leung et al. 2013). Most studies on CYP2E1 are 
in relation to liver diseases (Liu et al. 2005) including the 
metabolism of ethanol (Leon-Buitimea et al. 2012). Clini-
cal studies have shown that CYP2E1 is highly expressed in 
breast tumors compared to normal breast tissue (Kapucuo-
glu et al. 2003). The present study presents a novel mecha-
nism by which the dietary carcinogen PhIP can upregulate 
CYP2E1 expression, which consequently promotes oxidative 
stress in breast carcinoma cells.
Interestingly, PhIP-induced CYP2E1 mRNA only in 
ER-α-positive MCF-7 cells and not in the ER-α-negative 
MDA-MB-231 cells. The mechanism appears to involve 
activity of ER-α (Lauber et al. 2004) leading to upregulation 
of JAK/STAT3 pathway thereby inducing CYP2E1. In sup-
port of this, it has been reported that in MCF-7 cells ER-α 
can bind to STAT3/JAK2 leading to their upregulation (Binai 
et al. 2010). Importantly, CYP2E1 promoter region has mul-
tiple binding sites for STAT that are involved in CYP2E1 
upregulation (Patel et al. 2014). In future studies, it will be 
important to confirm the activation of STAT3 in this path-
way by investigating site-specific protein phosphorylation.
Our data also show that PhIP-mediated CYP2E1 induc-
tion leads to generation of oxidative stress that can be attenu-
ated by STAT3 inhibitor, suggesting involvement of both 
STAT3 and CYP2E1 in this process. However, although 
STAT3 inhibitor reduced the PhIP-mediated production 
of ROS, it was not completely eliminated, suggesting that 
PhIP might be generating ROS by more than one mecha-
nism. Consistent with this, Lauber et al. (Lauber et al. 2004; 
Lauber and Gooderham 2007) showed that PhIP activates 
the ERK/MAPK pathway and Chaudhary et al. showed that 
PhIP can generate ROS in MCF-10A cells via extracellular 
signal-regulated kinase (ERK) pathway activation (Choud-
hary et al. 2012).
Estradiol can induce DNA damage via ROS generation in 
MCF-7 but not in MDA-MB-231 cells (Mobley and Brue-
ggemeier 2004), thus suggesting the role of ER in oxidative 
DNA damage. Interestingly, Liehr et al. (2001) showed that 
estrogen can induce DNA damage directly by forming reac-
tive metabolites or indirectly by promoting reactive oxygen 
species (ROS) and redox cycling. These observations are 
consistent with data presented here and emphasise that estro-
genic agents like PhIP can generate oxidative stress leading 
to DNA damage.
Both in human and experimental studies, DNA damage 
by ROS production has been widely proposed as a major 
cause of cancer initiation and promotion (Loft and Poulsen 
1996; Poulsen et al. 1998; Waris and Ahsan 2006). Muta-
tions induced by ROS are primarily transversions of Gua-
nine to Thymine (Du et al. 1994; Higinbotham et al. 1992), 
and this is consistent with the preponderance of mutations 
induced by PhIP (Lynch et al. 1998; Yadollahi-Farsani et al. 
1996). The ability of PhIP to induce CYP2E1 has impor-
tance beyond ROS production since CYP2E1 also metab-
olizes low-molecular weight molecules such as ethanol, 
acetaminophen and procarcinogens like nitrosamines and 
azo compounds (Gonzalez 2005).
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Consumption of ethanol and red meat and breast 
cancer
Epidemiological studies provide a well-established link 
between lifestyle factors such as cooked meat and alcohol 
consumption and the development of breast cancer, yet the 
mechanistic basis of these associations is not well under-
stood (Leon-Buitimea et al. 2012; Singletary 1997). Rec-
reational consumption of ethanol in women can rapidly 
lead to mM plasma concentrations; such consumption can 
be frequent and addictive. Here, we propose a mechanism 
that links DNA damage, CYP1B1, CYP2E1, ROS and ER-α 
with the metabolism of ethanol and the cooked meat-derived 
procarcinogen PhIP (Fig. 8).
Following ethanol or PhIP treatment of human mammary 
cells, an increase in intracellular ROS levels was observed 
that was dependent on a functional ER-α; this is in agree-
ment with published observations using the breast carcinoma 
cell line MCF-10A (Leon-Buitimea et al. 2012) (Choudhary 
et al. 2012). Importantly, our study also shows that co-treat-
ments of ethanol and PhIP can increase the expression of 
CYP2E1 that in turn can generate oxidative stress leading to 
increased DNA damage. Additionally, it has been reported 
by ourselves and others that heterocyclic amines including 
PhIP are activated by one electron oxidation mechanisms 
such as with ROS, peroxidase and lactoperoxidase to DNA-
damaging species (Banning et al. 1993; Gorlewska-Roberts 
et al. 2004; Moonen et al. 2002).
Consumption of alcohol has been shown to increase the 
level of endogenous estrogens (Scoccianti et al. 2014a) and 
PhIP is estrogenic in nature. PhIP can induce the expression 
of CYP2E1 resulting in increased metabolism of alcohol 
and subsequent generation of ROS. PhIP is a powerful geno-
toxicant and mammary carcinogen and ROS is genotoxic 
and tumour promoting. It has been reported that ethanol 
can increase the invasion of breast cancer cells by modulat-
ing matrix metalloproteinase-2 (MMP-2) (Aye et al. 2004), 
while PhIP also increased the invasiveness of breast cancer 
cells (Lauber and Gooderham 2011), therefore, together 
these two compounds can potentially support and promote 
the progression of mammary cancer.
These activities, summarised in Fig. 8, provide a basis 
for explaining the observation that co-exposure to PhIP and 
ethanol can lead to the initiation and promotion of breast 
cancer. Both red meat and alcohol co-consumption is com-
mon in the western world, and both are associated with the 
incidence of breast cancer. This current study offers a mech-
anistic basis for this association.
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